Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Palvella Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Palvella Therapeutics Inc. December 2, 202497.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 2, 2026 | Palvella Therapeutics Inc. | Option exercise | +313 | $127.20 | $39,814 |
| Sep 2, 2026 | Palvella Therapeutics Inc. | Open-market sale | −313 | $157.00 | $49,141 |
| May 25, 2023 | Palvella Therapeutics Inc. | Open-market purchase | +10,000 | $0.85 | $8,500 |
Questions about Christopher P. Kiritsy
What boards is Christopher P. Kiritsy on?
Christopher P. Kiritsy sits on the board of Palvella Therapeutics Inc.
How long has Christopher P. Kiritsy served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.